265 related articles for article (PubMed ID: 28874373)
1. Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin.
Kolpen M; Lerche CJ; Kragh KN; Sams T; Koren K; Jensen AS; Line L; Bjarnsholt T; Ciofu O; Moser C; Kühl M; Høiby N; Jensen PØ
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874373
[TBL] [Abstract][Full Text] [Related]
2. Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas aeruginosa biofilm by hyperbaric oxygen treatment.
Kolpen M; Mousavi N; Sams T; Bjarnsholt T; Ciofu O; Moser C; Kühl M; Høiby N; Jensen PØ
Int J Antimicrob Agents; 2016 Feb; 47(2):163-7. PubMed ID: 26774522
[TBL] [Abstract][Full Text] [Related]
3. Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms.
Gade PAV; Olsen TB; Jensen PØ; Kolpen M; Høiby N; Henneberg KÅ; Sams T
PLoS One; 2018; 13(6):e0198909. PubMed ID: 29902223
[TBL] [Abstract][Full Text] [Related]
4. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
[TBL] [Abstract][Full Text] [Related]
5. Hyperbaric oxygen treatment increases killing of aggregating Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Møller SA; Jensen PØ; Høiby N; Ciofu O; Kragh KN; Bjarnsholt T; Kolpen M
J Cyst Fibros; 2019 Sep; 18(5):657-664. PubMed ID: 30711384
[TBL] [Abstract][Full Text] [Related]
6. Ambroxol inhibits mucoid conversion of Pseudomonas aeruginosa and contributes to the bactericidal activity of ciprofloxacin against mucoid P. aeruginosa biofilms.
Wang W; Yu J; He Y; Wang Z; Li F
APMIS; 2016 Jul; 124(7):611-8. PubMed ID: 27102839
[TBL] [Abstract][Full Text] [Related]
7. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
Kolpen M; Appeldorff CF; Brandt S; Mousavi N; Kragh KN; Aydogan S; Uppal HA; Bjarnsholt T; Ciofu O; Høiby N; Jensen PØ
Pathog Dis; 2016 Feb; 74(1):ftv086. PubMed ID: 26458402
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
[TBL] [Abstract][Full Text] [Related]
9. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
[TBL] [Abstract][Full Text] [Related]
10. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
[TBL] [Abstract][Full Text] [Related]
11. Sodium Nitrite Inhibits Killing of Pseudomonas aeruginosa Biofilms by Ciprofloxacin.
Zemke AC; Kocak BR; Bomberger JM
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799207
[TBL] [Abstract][Full Text] [Related]
12. Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.
Stewart PS; White B; Boegli L; Hamerly T; Williamson KS; Franklin MJ; Bothner B; James GA; Fisher S; Vital-Lopez FG; Wallqvist A
J Bacteriol; 2019 Nov; 201(22):. PubMed ID: 31501280
[TBL] [Abstract][Full Text] [Related]
13. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
[TBL] [Abstract][Full Text] [Related]
14. Micron Scale Spatial Measurement of the O
Klementiev AD; Jin Z; Whiteley M
mBio; 2020 Oct; 11(5):. PubMed ID: 33082251
[TBL] [Abstract][Full Text] [Related]
15. Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.
Jensen PØ; Kolpen M; Kragh KN; Kühl M
APMIS; 2017 Apr; 125(4):276-288. PubMed ID: 28407427
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
17. Phenazine production promotes antibiotic tolerance and metabolic heterogeneity in Pseudomonas aeruginosa biofilms.
Schiessl KT; Hu F; Jo J; Nazia SZ; Wang B; Price-Whelan A; Min W; Dietrich LEP
Nat Commun; 2019 Feb; 10(1):762. PubMed ID: 30770834
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of hyperbaric oxygen therapy in bacterial biofilm eradication.
Sanford NE; Wilkinson JE; Nguyen H; Diaz G; Wolcott R
J Wound Care; 2018 Jan; 27(Sup1):S20-S28. PubMed ID: 29334015
[TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of ciprofloxacin and gentamicin against a biofilm of Pseudomonas aeruginosa and its free-living forms.
Agarwal G; Kapil A; Kabra SK; Das BK; Dwivedi SN
Natl Med J India; 2005; 18(4):184-6. PubMed ID: 16252547
[TBL] [Abstract][Full Text] [Related]
20. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
Loo CY; Lee WH; Lauretani G; Scalia S; Cipolla D; Traini D; Young P; Ong HX
Pharm Res; 2018 Feb; 35(3):50. PubMed ID: 29417313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
